LBO — RIVERVIEW MEDICAL CENTER
IRR: 21.2% | MOIC: 2.62x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
21.2%
IRR
2.62x
MOIC
$209.0M
Entry EV
$375.9M
Exit EV
$107.5M
Equity Invested
Sources & Uses
S&UTotal · $209.0M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $81.2M | 38.8% | |
| Sub Debt | $20.3M | 9.7% | |
| Equity | $107.5M | 51.5% | |
| Enterprise Value | $202.9M | 97.1% | |
| Transaction Fees | $6.1M | 2.9% | |
| Total Uses | $209.0M | 100.0% |
Interpretation
INTAt 2.62x MOIC and 21.2% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $35.8M |
| Exit Ev | $375.9M |
| Net Debt At Exit | $94.1M |
| Equity At Exit | $281.8M |
| Equity Invested | $107.5M |
| Total Value Created | $174.3M |
| Value From Growth | $162.9M |
| Value From Multiple | $10.1M |
| Value From Deleveraging | $7.4M |